Istanbul Medipol University Hospital
medipol.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
350
Active
51
Phase 3
0
Total enrollment
28,760
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Fentanyl | — | — | — | — | — | 1 | |
| Meperidine | — | — | — | — | — | 1 | |
| Paracetamol | — | — | — | — | — | 1 | |
| Lidocaine Hydrochloride 2% Injection Solution | — | — | — | — | — | 1 | |
| Somatostatin | — | — | — | — | — | 1 | |
| Terlipressin | — | — | — | — | — | 1 |
Next readouts
- 2026-07-30
- 2027-03-15
- 2027-07
Top conditions
- Low Back Pain9
- Periodontitis8
- Pain8
- Pulmonary Rehabilitation8
- Quality of Life7
- Exercise7
- Stroke6
- Pes Planus6
Frequently asked questions about Istanbul Medipol University Hospital
- How many clinical trials does Istanbul Medipol University Hospital have on ClinicalTrials.gov?
- Istanbul Medipol University Hospital is listed as the lead sponsor on 350 clinical trials in ClinicalTrials.gov, 51 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istanbul Medipol University Hospital's trials are in Phase 3?
- 0 of Istanbul Medipol University Hospital's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Istanbul Medipol University Hospital focus on?
- Istanbul Medipol University Hospital's most-studied conditions on ClinicalTrials.gov are Low Back Pain, Periodontitis, Pain, Pulmonary Rehabilitation, Quality of Life.
- When are Istanbul Medipol University Hospital's next clinical trial readouts?
- Istanbul Medipol University Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Ultrasonographic Assessment of Muscle Echogenicity in Myofascial Pain”, expected around 2026-07-30.